Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study

Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study

Abstract Objectives The aim of this study was to evaluate the role of antiviral drugs in reducing the risk of developing severe illness in patients with moderate COVID-19 pneumonia. Methods This retrospective cohort study included 403 adult patients with moderate COVID-19 pneumonia who were admitted...

Full description

Bibliographic Details
Main Authors: Peng Yin, Juan Meng, Jincheng Chen, Junxiao Gao, Dongqi Wang, Shuyan Liu, Qinglong Guo, Muchun Zhu, Gengwei Zhang, Yingxia Liu, Ye Li, Guoliang Zhang
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Virology Journal
Subjects:
Arbidol
Interferon alpha-1b
Severity rate
COVID-19
Antiviral agents
Online Access:https://doi.org/10.1186/s12985-021-01617-w

Internet

https://doi.org/10.1186/s12985-021-01617-w

Similar Items